Literature DB >> 15870622

Effects of indomethacin and celecoxib on renal function in athletes.

Jordan Baker1, James D Cotter, David F Gerrard, Melanie L Bell, Robert J Walker.   

Abstract

INTRODUCTION: Strenuous exercise induces a marked reduction in renal hemodynamics. Prostaglandins (PG) play an important role in maintaining renal integrity in the face of hemodynamic changes. Inhibition of cyclooxygenase (COX) and thus PG formation can further compromise renal perfusion. The role of selective COX-2 inhibition on renal hemodynamics during exercise has not been investigated.
METHODS: Twelve healthy males (22-47 yr) took part in a randomized placebo controlled study investigating the effects of nonselective COX inhibition (indomethacin) and COX-2 selective inhibition (celecoxib) on renal hemodynamics during exercise. Renal blood flow (RBF), glomerular filtration rate (GFR), and free water clearance were measured using standard clearance techniques. Each experimental session was performed at least a week apart. The medications were taken for 36 h before study with the last dose at 0700 h on the day of study. Following baseline studies, each participant exercised for 30 min at 80% of their maximal aerobic power. Renal function was monitored for 2 h post-recovery.
RESULTS: RBF and GFR fell by 40% after exercise with no significant difference between placebo, indomethacin, or celecoxib. Indomethacin (-2.43 +/- 0.95 mL x min(-1), P < 0.007) and celecoxib (-3.88 +/- 0.94 mL x min(-1), P < 0.0001) significantly reduced free water clearance compared with placebo during recovery.
CONCLUSION: This study has confirmed that selective and nonselective COX inhibition can induce significant inhibition of free water clearance, indicating that these acute changes are regulated predominantly via COX-2. Acute cerebral edema with hyponatremia has been reported after major endurance sporting events. Identifiable risk factors include excessive hydration and use of NSAID. Impaired free water clearance during exercise potentiated by COX inhibition provides a pathophysiological explanation for these observations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870622     DOI: 10.1249/01.mss.0000162700.66214.ce

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  10 in total

Review 1.  Use of prescription drugs in athletes.

Authors:  Antti Alaranta; Hannu Alaranta; Ilkka Helenius
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

2.  Preventive Health Perspective in Sports Medicine: The Trend at the Use of Medications and Nutritional Supplements during 5 Years Period between 2003 and 2008 in Football.

Authors:  Ethem Kavukcu; Kamil Mehmet Burgazlı
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

3.  Proof of concept: hypovolemic hyponatremia may precede and augment creatine kinase elevations during an ultramarathon.

Authors:  Ross S Cairns; Tamara Hew-Butler
Journal:  Eur J Appl Physiol       Date:  2016-01-08       Impact factor: 3.078

4.  Adherence to Follow-Up Recommendations by Triathlon Competitors Receiving Event Medical Care.

Authors:  Jeremy D Joslin; Jarem B Lloyd; Nikoli Copeli; Derek R Cooney
Journal:  Emerg Med Int       Date:  2017-01-19       Impact factor: 1.112

5.  Use of Non-Steroidal Anti-Inflammatory Drugs among Participants in a Mountain Ultramarathon Event.

Authors:  Sonia Martínez; Antoni Aguiló; Carlos Moreno; Leticia Lozano; Pedro Tauler
Journal:  Sports (Basel)       Date:  2017-01-29

6.  Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis.

Authors:  Ling Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Musculoskeletal performance and hydration status.

Authors:  Joseph A Rothenberg; André Panagos
Journal:  Curr Rev Musculoskelet Med       Date:  2008-06

8.  The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006.

Authors:  P Tscholl; A Junge; J Dvorak
Journal:  Br J Sports Med       Date:  2008-02-28       Impact factor: 13.800

Review 9.  Physiopathological, Epidemiological, Clinical and Therapeutic Aspects of Exercise-Associated Hyponatremia.

Authors:  Caterina Urso; Salvatore Brucculeri; Gregorio Caimi
Journal:  J Clin Med       Date:  2014-11-12       Impact factor: 4.241

10.  Non-steroidal Anti-inflammatory Drug Consumption in a Multi-Stage and a 24-h Mountain Bike Competition.

Authors:  Daniela Chlíbková; Marina Ronzhina; Pantelis T Nikolaidis; Thomas Rosemann; Beat Knechtle
Journal:  Front Physiol       Date:  2018-09-10       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.